Option Volumes Soars Amid Opko Health Inc. (OPK) Breakout

Opko Health Inc. is up 9%, thanks to a licensing deal with Pfizer Inc.

Digital Content Group
Dec 15, 2014 at 1:48 PM
facebook twitter linkedin


Opko Health Inc. (NYSE:OPK) has surged roughly 9% to trade at $8.92, after striking a nearly $300 million drug-licensing deal with Pfizer Inc. (NYSE:PFE). Option traders have taken notice, too, as intraday volume is running at nearly triple the expected rate -- with possible buy-to-open activity at the January 2015 9-strike call.

Today's bullish gap has OPK trading above its year-to-date breakeven mark of $8.44, as well as several key trendlines. Specifically, the shares have broken north of their 80-, 160-, and 200-day moving averages, which have acted as levels of resistance in recent months. In fact, the last time the stock closed atop this trio of trendlines was Aug. 19.

Short-covering activity may be helping to fuel Opko Health Inc.'s (NYSE:OPK) intraday gains. More than one-fifth of the equity's float is dedicated to short interest, and it would take around six weeks to buy back these bearish bets, at OPK's average daily trading volume.

 

Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

 
Schaeffer's Daily Bulletin Offer
 


 


 
Special Offers from Schaeffer's Trading Partners